Literature DB >> 21828121

CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura.

Francesca Rossi1, Silvia Mancusi, Giulia Bellini, Domenico Roberti, Francesca Punzo, Simona Vetrella, Sofia Maria Rosaria Matarese, Bruno Nobili, Sabatino Maione, Silverio Perrotta.   

Abstract

Immune thrombocytopenic purpura is an acquired autoimmune disorder that is the most common cause of thrombocytopenia in children. The endocannabinoid system is involved in immune regulation. We evaluated a common missense variant (CAA/CGG; Q63R) of the gene encoding the cannabinoid receptor type 2 (GeneID 1269) in 190 children with immune thrombocytopenic purpura and 600 healthy controls. The allelic frequencies and genotype distribution of the polymorphism in the patients were significant compared to control samples (P=0.006 and P=0.0001, respectively). Interestingly, when acute and chronic immune thrombocytopenic purpura patients were analyzed separately with respect to controls, a significant overrepresentation of the RR genotype and of the R allele was observed only for the chronic form (P=0.00021 and P=0.011, respectively). The relative odds ratio suggested the risk of developing chronic form was more than double in immune thrombocytopenic purpura children homozygous for the variant (odds ratio=2.349, 95% CI: 1.544-3.573; P<0.001).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21828121      PMCID: PMC3232275          DOI: 10.3324/haematol.2011.045732

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  21 in total

Review 1.  Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation.

Authors:  Guy A Cabral; LaToya Griffin-Thomas
Journal:  Expert Rev Mol Med       Date:  2009-01-20       Impact factor: 5.600

2.  Idiopathic thrombocytopenic purpura: a guideline for diagnosis and management of children and adults. American Society of Hematology.

Authors:  J N George; S H Woolf; G E Raskob
Journal:  Ann Med       Date:  1998-02       Impact factor: 4.709

3.  Type 1 and type 2 T-cell profiles in idiopathic thrombocytopenic purpura.

Authors:  Tingting Wang; Hui Zhao; He Ren; Jianhai Guo; Maoqiang Xu; Renchi Yang; Zhong Chao Han
Journal:  Haematologica       Date:  2005-07       Impact factor: 9.941

Review 4.  The pathogenesis of immune thrombocytopaenic purpura.

Authors:  Nichola Cooper; James Bussel
Journal:  Br J Haematol       Date:  2006-05       Impact factor: 6.998

5.  Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations.

Authors:  S Galiègue; S Mary; J Marchand; D Dussossoy; D Carrière; P Carayon; M Bouaboula; D Shire; G Le Fur; P Casellas
Journal:  Eur J Biochem       Date:  1995-08-15

Review 6.  The role of autoreactive T-cells in the pathogenesis of idiopathic thrombocytopenic purpura.

Authors:  Masataka Kuwana; Yasuo Ikeda
Journal:  Int J Hematol       Date:  2005-02       Impact factor: 2.490

7.  Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders.

Authors:  Jack C Sipe; Nathalie Arbour; Alexandra Gerber; Ernest Beutler
Journal:  J Leukoc Biol       Date:  2005-04-21       Impact factor: 4.962

8.  Functional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depression.

Authors:  Emmanuel S Onaivi; Hiroki Ishiguro; Jian-Ping Gong; Sejal Patel; Paul A Meozzi; Lester Myers; Alex Perchuk; Zoila Mora; Patricia A Tagliaferro; Eileen Gardner; Alicia Brusco; B Emmanuel Akinshola; Qing-Rong Liu; Sanika S Chirwa; Bruce Hope; Javier Lujilde; Toshiya Inada; Shinya Iwasaki; David Macharia; Lindsey Teasenfitz; Tadao Arinami; George R Uhl
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

9.  Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura.

Authors:  Willemijn B Breunis; Edwin van Mirre; Marrie Bruin; Judy Geissler; Martin de Boer; Marjolein Peters; Dirk Roos; Masja de Haas; Harry R Koene; Taco W Kuijpers
Journal:  Blood       Date:  2007-09-07       Impact factor: 22.113

10.  The cannabinoid receptor 2 is critical for the host response to sepsis.

Authors:  Johannes Tschöp; Kevin R Kasten; Ruben Nogueiras; Holly S Goetzman; Cynthia M Cave; Lisa G England; Jonathan Dattilo; Alex B Lentsch; Matthias H Tschöp; Charles C Caldwell
Journal:  J Immunol       Date:  2009-06-12       Impact factor: 5.422

View more
  20 in total

1.  Immune thrombocytopenia in children and adults: what's the same, what's different?

Authors:  Harald Schulze; Gerhard Gaedicke
Journal:  Haematologica       Date:  2011-12       Impact factor: 9.941

2.  The endocannabinoid system in the baboon (Papio spp.) as a complex framework for developmental pharmacology.

Authors:  Iram P Rodriguez-Sanchez; Josee Guindon; Marco Ruiz; M Elizabeth Tejero; Gene Hubbard; Laura E Martinez-de-Villarreal; Hugo A Barrera-Saldaña; Edward J Dick; Anthony G Comuzzie; Natalia E Schlabritz-Loutsevitch
Journal:  Neurotoxicol Teratol       Date:  2016-06-18       Impact factor: 3.763

3.  Study of cannabinoid receptor 2 Q63R gene polymorphism in Lebanese patients with rheumatoid arthritis.

Authors:  Morouj Ismail; Ghada Khawaja
Journal:  Clin Rheumatol       Date:  2018-07-21       Impact factor: 2.980

Review 4.  What we know and do not know about the cannabinoid receptor 2 (CB2).

Authors:  Anna Maria Malfitano; Sreemanti Basu; Katarzyna Maresz; Maurizio Bifulco; Bonnie N Dittel
Journal:  Semin Immunol       Date:  2014-05-28       Impact factor: 11.130

5.  The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immunosuppressive properties.

Authors:  Francesca Rossi; Maria Ester Bernardo; Giulia Bellini; Livio Luongo; Antonella Conforti; Iolanda Manzo; Francesca Guida; Luigia Cristino; Roberta Imperatore; Stefania Petrosino; Bruno Nobili; Vincenzo Di Marzo; Franco Locatelli; Sabatino Maione
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

Review 6.  The Centenary of Immune Thrombocytopenia - Part 1: Revising Nomenclature and Pathogenesis.

Authors:  Rita Consolini; Annalisa Legitimo; Maria Costanza Caparello
Journal:  Front Pediatr       Date:  2016-10-19       Impact factor: 3.418

7.  The Cannabinoid Receptor 2 Q63R Variant Modulates the Relationship between Childhood Obesity and Age at Menarche.

Authors:  Giulia Bellini; Anna Grandone; Marco Torella; Emanuele Miraglia del Giudice; Bruno Nobili; Laura Perrone; Sabatino Maione; Francesca Rossi
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240

8.  Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C.

Authors:  Nicola Coppola; Rosa Zampino; Caterina Sagnelli; Giulia Bellini; Aldo Marrone; Maria Stanzione; Nicolina Capoluongo; Adriana Boemio; Carmine Minichini; Luigi Elio Adinolfi; Sabatino Maione; Emanuele Miraglia Del Giudice; Evangelista Sagnelli; Francesca Rossi
Journal:  PLoS One       Date:  2014-06-18       Impact factor: 3.240

9.  Platelet count recovery after intravenous immunoglobulin predicts a favorable outcome in children with immune thrombocytopenia.

Authors:  Hyoung Soo Choi; Mi Hong Ji; Sung Jin Kim; Hyo Seop Ahn
Journal:  Blood Res       Date:  2016-06-23

10.  Signaling through the type 2 cannabinoid receptor regulates the severity of acute and chronic graft-versus-host disease.

Authors:  Cheng Yin Yuan; Vivian Zhou; Garrett Sauber; Todd Stollenwerk; Richard Komorowski; Alicia López; Rosa María Tolón; Julian Romero; Cecilia J Hillard; William R Drobyski
Journal:  Blood       Date:  2021-03-04       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.